Although schizophrenia is a heterogeneous clinical syndrome, one important question that remains largely unanswered is whether the complex and subtle deficits revealed by MRI could be used as objective biomarkers to resolve neurobiological heterogeneity within this disorder. Using clustering analysis and structural MRI, first-episode schizophrenia patients were classified into three subtypes. The three subtypes of patients showed different morphological alterations.
This abstract and the presentation materials are available to members only; a login is required.